Display options
Cite
Tursi A, Nenna R. Omalizumab-induced colitis. Dig Liver Dis. 2020;53(10):1356-1358doi: 10.1016/j.dld.2020.08.017.
Tursi, A., & Nenna, R. (2021). Omalizumab-induced colitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(10), 1356-1358. https://doi.org/10.1016/j.dld.2020.08.017
Tursi, Antonio, and Nenna, Rosanna. "Omalizumab-induced colitis." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,10 (2021): 1356-1358. doi: https://doi.org/10.1016/j.dld.2020.08.017
Tursi A, Nenna R. Omalizumab-induced colitis. Dig Liver Dis. 2021 Oct;53(10):1356-1358. doi: 10.1016/j.dld.2020.08.017. Epub 2020 Sep 04. PMID: 32893174.
Copy Download .nbib Format: NLM
Share it on

Dig Liver Dis. 2021 Oct;53(10):1356-1358. doi: 10.1016/j.dld.2020.08.017. Epub 2020 Sep 04.

Omalizumab-induced colitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Antonio Tursi, Rosanna Nenna

Affiliations

  1. Territorial Gastroenterology Service, ASL BAT, Andria, BT, Italy. Electronic address: [email protected].
  2. Division of Pathology, "Lorenzo Bonomo" Hospital, ASL BAT, Andria, BT, Italy.

PMID: 32893174 DOI: 10.1016/j.dld.2020.08.017

[No abstract available.]

Keywords: Adverse event; Immune-mediated colitis; Omalizumab

Conflict of interest statement

Declaration of Competing Interest None.

Publication Types